Vector BioMed Expands LENTIVERSE(TM) Platform and Unveils New Brand Identity to Close the Gap Between CGT Innovation and Patient Access

The expansion of LENTIVERSE (TM) platform introduces "One Lentiviral Vector Platform, Two Paths to Advance Cures," aligning scientific rigor with transparent economics and global accessibility.
HealthLeaders Media

Increase Healthcare System Transparency by Utilizing Cost Growth Benchmarking Models

A new Manatt and Robert Wood Johnson Foundation white paper details how healthcare systems can increase price transparency by using cost growth benchmarking models. States can increase price ...

Vector BioMed Expands LENTIVERSE™ Platform and Unveils New Brand Identity to Close the Gap Between CGT Innovation and Patient Access

Vector BioMed, a leading lentiviral vector supplier and contract vector development and manufacturing organization (CVDMO), today announced the expansion of its LENTIVERSE™ platform alongside the ...